These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuroprotective Potential of HC070, a Potent TRPC5 Channel Inhibitor in Parkinson's Disease Models: A Behavioral and Mechanistic Study. Vaidya B; Roy I; Sharma SS ACS Chem Neurosci; 2022 Sep; 13(18):2728-2742. PubMed ID: 36094343 [TBL] [Abstract][Full Text] [Related]
3. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis. Jhuo CF; Chen CJ; Tzen JTC; Chen WY Environ Toxicol; 2024 Jul; 39(7):4022-4034. PubMed ID: 38622810 [TBL] [Abstract][Full Text] [Related]
4. Amelioration of Parkinson's disease by pharmacological inhibition and knockdown of redox sensitive TRPC5 channels: Focus on mitochondrial health. Vaidya B; Gupta P; Laha JK; Roy I; Sharma SS Life Sci; 2023 Sep; 328():121871. PubMed ID: 37352915 [TBL] [Abstract][Full Text] [Related]
5. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease. Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells. Piao Y; Kim HG; Oh MS; Pak YK Biochim Biophys Acta; 2012 May; 1820(5):577-85. PubMed ID: 21856379 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease. Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150 [TBL] [Abstract][Full Text] [Related]
8. The novel tetramethylpyrazine bis-nitrone (TN-2) protects against MPTP/MPP+-induced neurotoxicity via inhibition of mitochondrial-dependent apoptosis. Xu D; Duan H; Zhang Z; Cui W; Wang L; Sun Y; Lang M; Hoi PM; Han Y; Wang Y; Lee SM J Neuroimmune Pharmacol; 2014 Mar; 9(2):245-58. PubMed ID: 24233519 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP Rani L; Ghosh B; Ahmad MH; Mondal AC Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo. Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623 [TBL] [Abstract][Full Text] [Related]
11. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway. Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589 [TBL] [Abstract][Full Text] [Related]
12. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Lee DH; Kim CS; Lee YJ Food Chem Toxicol; 2011 Jan; 49(1):271-80. PubMed ID: 21056612 [TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro. Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806 [TBL] [Abstract][Full Text] [Related]
14. Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease. Fu X; Qu L; Xu H; Xie J Exp Neurol; 2024 May; 375():114724. PubMed ID: 38365133 [TBL] [Abstract][Full Text] [Related]
15. Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson's disease. Jeong JS; Piao Y; Kang S; Son M; Kang YC; Du XF; Ryu J; Cho YW; Jiang HH; Oh MS; Hong SP; Oh YJ; Pak YK Sci Rep; 2018 Oct; 8(1):15953. PubMed ID: 30374025 [TBL] [Abstract][Full Text] [Related]
16. RIPK1 inhibitor ameliorates the MPP Liu J; Hu H; Wu B Brain Res; 2021 Apr; 1757():147310. PubMed ID: 33524379 [TBL] [Abstract][Full Text] [Related]
18. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Ren ZL; Wang CD; Wang T; Ding H; Zhou M; Yang N; Liu YY; Chan P Acta Pharmacol Sin; 2019 Apr; 40(4):441-450. PubMed ID: 29991712 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons. Ye Q; Huang W; Li D; Si E; Wang J; Wang Y; Chen C; Chen X Mol Neurobiol; 2016 Aug; 53(6):3756-3770. PubMed ID: 26141122 [TBL] [Abstract][Full Text] [Related]
20. The Study of Overexpression of Peroxiredoxin-2 Reduces MPP Liu M; Zuo S; Guo X; Peng J; Xing Y; Guo Y; Li C; Xing H Neurochem Res; 2023 Jul; 48(7):2129-2137. PubMed ID: 36808393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]